Clinical trial
Megestrol and Exercise in Treating Patients With Cancer-Related Weight Loss
NCT00004912 · Northwestern University, Other · Completed
Key facts
| NCT number | NCT00004912 |
|---|---|
| Title | Megestrol and Exercise in Treating Patients With Cancer-Related Weight Loss |
| Official title | Phase II Trial of Progressive Resistance Training With Megestrol Acetate for the Treatment of Cancer-Related Weight Loss |
| Lead sponsor | Northwestern University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cachexia, Fatigue, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug, Procedure |
| Interventions | megestrol acetate, physical therapy |
| Start date | Jan 1, 2000 |
| Primary completion | Nov 1, 2003 |
| Completion | Nov 1, 2003 |
| First posted | Mar 3, 2004 |
| Last update posted | May 30, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: